Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Chemical Research in Toxicology
|
July 29, 2024
Quantum-Mechanics Calculations Elucidate Skin-Sensitizing Pharmaceutical Compounds
Jakub Kostal, Adelina Voutchkova-Kostal, Joel P Bercu, et al.
Regulatory Toxicology and Pharmacology : RTP
|
April 16, 2021
Use of less-than-lifetime (LTL) durational limits for nitrosamines: Case study of N-Nitrosodiethylamine (NDEA)
Joel P Bercu, Melisa Masuda-Herrera, George Johnson, et al.
Regulatory Toxicology and Pharmacology : RTP
|
September 25, 2023
Harmonisation of read-across methodology for drug substance extractables and leachables (E&Ls)
Melisa Masuda-Herrera, Hannah T Rosen, Anders Burild, et al.
Regulatory Toxicology and Pharmacology : RTP
|
August 7, 2021
Calculating qualified non-mutagenic impurity levels: Harmonization of approaches
Jessica C Graham, Mark W Powley, Erika Udovic, et al.
Biotechnology and Bioengineering
|
January 10, 2026
Assessment and Control of Host Cell Proteins in Biologics: Survey of Industry Practices and a Vision for Harmonization
Jessica Graham, Sathanandam S Anand, Joel Bercu, et al.
Critical Reviews in Toxicology
|
June 15, 2022
Framework for sensitization assessment of extractables and leachables in pharmaceuticals
Patricia Parris, Geraldine Whelan, Anders Burild, et al.
Regulatory Toxicology and Pharmacology : RTP
|
August 14, 2022
Setting impurity limits for endogenous substances: Recommendations for a harmonized procedure and an example using fatty acids
Robert A Jolly, Suren Bandara, Joel Bercu, et al.
PDA Journal of Pharmaceutical Science and Technology
|
September 15, 2023
Sensitization Assessment of Extractables and Leachables in Pharmaceuticals: ELSIE Database Analysis
Patricia Parris, Geraldine Whelan, Anders Burild, et al.
Regulatory Toxicology and Pharmacology : RTP
|
October 10, 2020
Considerations when deriving compound-specific limits for extractables and leachables from pharmaceutical products: Four case studies
Patricia Parris, Elizabeth A Martin, Brad Stanard, et al.
Regulatory Toxicology and Pharmacology : RTP
|
May 31, 2023
Acceptable intakes (AIs) for 11 small molecule N-nitrosamines (NAs)
Joel P Bercu, Melisa Masuda-Herrera, Alejandra Trejo-Martin, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Chemical Research in Toxicology
|
July 29, 2024
Quantum-Mechanics Calculations Elucidate Skin-Sensitizing Pharmaceutical Compounds
Jakub Kostal, Adelina Voutchkova-Kostal, Joel P Bercu, et al.
Regulatory Toxicology and Pharmacology : RTP
|
April 16, 2021
Use of less-than-lifetime (LTL) durational limits for nitrosamines: Case study of N-Nitrosodiethylamine (NDEA)
Joel P Bercu, Melisa Masuda-Herrera, George Johnson, et al.
Regulatory Toxicology and Pharmacology : RTP
|
September 25, 2023
Harmonisation of read-across methodology for drug substance extractables and leachables (E&Ls)
Melisa Masuda-Herrera, Hannah T Rosen, Anders Burild, et al.
Regulatory Toxicology and Pharmacology : RTP
|
August 7, 2021
Calculating qualified non-mutagenic impurity levels: Harmonization of approaches
Jessica C Graham, Mark W Powley, Erika Udovic, et al.
Biotechnology and Bioengineering
|
January 10, 2026
Assessment and Control of Host Cell Proteins in Biologics: Survey of Industry Practices and a Vision for Harmonization
Jessica Graham, Sathanandam S Anand, Joel Bercu, et al.
Critical Reviews in Toxicology
|
June 15, 2022
Framework for sensitization assessment of extractables and leachables in pharmaceuticals
Patricia Parris, Geraldine Whelan, Anders Burild, et al.
Regulatory Toxicology and Pharmacology : RTP
|
August 14, 2022
Setting impurity limits for endogenous substances: Recommendations for a harmonized procedure and an example using fatty acids
Robert A Jolly, Suren Bandara, Joel Bercu, et al.
PDA Journal of Pharmaceutical Science and Technology
|
September 15, 2023
Sensitization Assessment of Extractables and Leachables in Pharmaceuticals: ELSIE Database Analysis
Patricia Parris, Geraldine Whelan, Anders Burild, et al.
Regulatory Toxicology and Pharmacology : RTP
|
October 10, 2020
Considerations when deriving compound-specific limits for extractables and leachables from pharmaceutical products: Four case studies
Patricia Parris, Elizabeth A Martin, Brad Stanard, et al.
Regulatory Toxicology and Pharmacology : RTP
|
May 31, 2023
Acceptable intakes (AIs) for 11 small molecule N-nitrosamines (NAs)
Joel P Bercu, Melisa Masuda-Herrera, Alejandra Trejo-Martin, et al.
Page
of 2